{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:12:45Z","timestamp":1791238365550,"version":"4.1.0"},"reference-count":81,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,26]]},"abstract":"<jats:p>This issue\u2019s How I Treat article offers valuable insights to clinicians caring for patients with congenital antithrombin deficiency and is likely to be especially helpful for clinicians who only see a few cases in their career.<\/jats:p>","DOI":"10.1182\/blood.2019002927","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T15:53:55Z","timestamp":1572537235000},"page":"2346-2353","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":56,"title":["How I treat patients with hereditary antithrombin deficiency"],"prefix":"10.1182","volume":"134","author":[{"given":"Ingrid","family":"Pabinger","sequence":"first","affiliation":[{"name":"Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9613-8658","authenticated-orcid":false,"given":"Johannes","family":"Thaler","sequence":"additional","affiliation":[{"name":"Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"suppl 1","key":"2019122611525797700_B1","first-page":"S67","article-title":"Antithrombin deficiency and its laboratory diagnosis","volume":"48","author":"Muszbek","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"2019122611525797700_B2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.2001.02981.x","article-title":"Investigation and management of heritable thrombophilia","volume":"114","author":"Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"2019122611525797700_B3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"issue":"3","key":"2019122611525797700_B4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1357-2725(03)00244-9","article-title":"Antithrombin: in control of coagulation","volume":"36","author":"Quinsey","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"suppl 1","key":"2019122611525797700_B5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1538-7836.2007.02516.x","article-title":"Serpins in thrombosis, hemostasis and fibrinolysis","volume":"5","author":"Rau","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019122611525797700_B6","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1172\/JCI200318234","article-title":"Heparan sulfate: antithrombotic or not?","volume":"111","author":"Weitz","year":"2003","journal-title":"J Clin Invest"},{"key":"2019122611525797700_B7","first-page":"516","article-title":"Inherited antithrombin deficiency causing thrombophilia","volume":"13","author":"Egeberg","year":"1965","journal-title":"Thromb Diath Haemorrh"},{"issue":"1","key":"2019122611525797700_B8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archinte.1937.00170170088006","article-title":"Essential thrombophilia report of five cases","volume":"59","author":"Nygaard","year":"1937","journal-title":"Arch Intern Med (Chic)"},{"key":"2019122611525797700_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2016.1.1","article-title":"Inherited thrombophilia: a double-edged sword","volume":"2016","author":"Middeldorp","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2019122611525797700_B10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlb\u00e4ck","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6475","key":"2019122611525797700_B11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"issue":"10","key":"2019122611525797700_B12","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"issue":"15","key":"2019122611525797700_B13","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.109.906347","article-title":"Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A","volume":"121","author":"Lijfering","year":"2010","journal-title":"Circulation"},{"issue":"9757","key":"2019122611525797700_B14","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(10)60962-2","article-title":"Risk assessment for recurrent venous thrombosis","volume":"376","author":"Kyrle","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"2019122611525797700_B15","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1182\/blood-2008-10-184879","article-title":"Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives","volume":"113","author":"Lijfering","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019122611525797700_B16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1625983","article-title":"Risk of venous thrombosis in antithrombin deficiency: a systematic review and Bayesian meta-analysis","volume":"44","author":"Croles","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"2019122611525797700_B17","article-title":"Incidence and features of thrombosis in children with inherited antithrombin deficiency [published online ahead of print 11 April","author":"de la Morena-Barrio","journal-title":"Haematologica"},{"issue":"6","key":"2019122611525797700_B18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00277-017-2965-2","article-title":"Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications","volume":"96","author":"Kraft","year":"2017","journal-title":"Ann Hematol"},{"key":"2019122611525797700_B19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2018.11.006","article-title":"The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications","volume":"173","author":"Kovac","year":"2019","journal-title":"Thromb Res"},{"issue":"12","key":"2019122611525797700_B20","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1161\/STROKEAHA.110.595199","article-title":"Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good?","volume":"41","author":"Morris","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"2019122611525797700_B21","first-page":"272","article-title":"Myocardial infarction under the age of 36: prevalence of thrombophilic disorders","volume":"90","author":"Rallidis","year":"2003","journal-title":"Thromb Haemost"},{"key":"2019122611525797700_B22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.thromres.2017.08.023","article-title":"Homozygous antithrombin deficiency type II causing neonatal thrombosis","volume":"158","author":"Swoboda","year":"2017","journal-title":"Thromb Res"},{"issue":"4","key":"2019122611525797700_B23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jth.13252","article-title":"Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort","volume":"14","author":"Gindele","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2019122611525797700_B24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2018.04.004","article-title":"Evaluation of endogenous thrombin potential among patients with antithrombin deficiency","volume":"166","author":"Kovac","year":"2018","journal-title":"Thromb Res"},{"issue":"2","key":"2019122611525797700_B25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/rth2.12025","article-title":"Defects of splicing in antithrombin deficiency","volume":"1","author":"de la Morena-Barrio","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"2019122611525797700_B26","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1160\/TH16-08-0635","article-title":"Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency","volume":"117","author":"Alhenc-Gelas","year":"2017","journal-title":"Thromb Haemost"},{"issue":"2","key":"2019122611525797700_B27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1160\/TH13-05-0402","article-title":"Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency","volume":"111","author":"Luxembourg","year":"2014","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019122611525797700_B28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bjh.12842","article-title":"Clinical presentation and molecular basis of congenital antithrombin deficiency in children: a cohort study","volume":"166","author":"Kumar","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2019122611525797700_B29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.1990.tb02541.x","article-title":"Antithrombin III and procoagulant activity: sex differences and effects of the menopause","volume":"74","author":"Meade","year":"1990","journal-title":"Br J Haematol"},{"issue":"1","key":"2019122611525797700_B30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2141.1990.tb02635.x","article-title":"Antithrombin III activity in healthy blood donors: age and sex related changes and prevalence of asymptomatic deficiency","volume":"75","author":"Tait","year":"1990","journal-title":"Br J Haematol"},{"issue":"1","key":"2019122611525797700_B31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1994.tb04878.x","article-title":"Prevalence of antithrombin deficiency in the healthy population","volume":"87","author":"Tait","year":"1994","journal-title":"Br J Haematol"},{"issue":"5","key":"2019122611525797700_B32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001721-199210000-00005","article-title":"Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening","volume":"3","author":"Pabinger","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"2019122611525797700_B33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1538-7836.2005.01197.x","article-title":"Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)","volume":"3","author":"Vossen","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019122611525797700_B34","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.ATV.16.6.742","article-title":"Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study","volume":"16","author":"Pabinger","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2019122611525797700_B35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-138-2-200301210-00014","article-title":"Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system","volume":"138","author":"Crowther","year":"2003","journal-title":"Ann Intern Med"},{"issue":"7","key":"2019122611525797700_B36","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood.V92.7.2353","article-title":"Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families","volume":"92","author":"Martinelli","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2019122611525797700_B37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0308-2261(21)00229-0","article-title":"Antithrombin III deficiency and thromboembolism","volume":"10","author":"Thaler","year":"1981","journal-title":"Clin Haematol"},{"issue":"9383","key":"2019122611525797700_B38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"2019122611525797700_B39","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0038-1642480","article-title":"Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication","volume":"71","author":"Pabinger","year":"1994","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019122611525797700_B40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/AOG.0000000000001347","article-title":"Pregnancy-related venous thromboembolism risk in asymptomatic women with antithrombin deficiency: a systematic review","volume":"127","author":"Rh\u00e9aume","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2019122611525797700_B41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/bjh.14658","article-title":"SERPINC1 gene mutations in antithrombin deficiency","volume":"178","author":"Mulder","year":"2017","journal-title":"Br J Haematol"},{"issue":"10","key":"2019122611525797700_B42","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00431-019-03433-5","article-title":"Genotype phenotype correlation in a pediatric population with antithrombin deficiency","volume":"178","author":"Kovac","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2019122611525797700_B43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V43.2.219.219","article-title":"Familial thrombosis due to antithrombin 3 deficiency","volume":"43","author":"Marciniak","year":"1974","journal-title":"Blood"},{"issue":"8050","key":"2019122611525797700_B44","first-page":"1231","article-title":"Effect of heparin and warfarin on antithrombin III","volume":"2","author":"O\u2019Brien","year":"1977","journal-title":"Lancet"},{"issue":"7","key":"2019122611525797700_B45","doi-asserted-by":"crossref","first-page":"967","DOI":"10.5858\/arpa.2013-0065-OA","article-title":"Antithrombin levels are unaffected by warfarin use","volume":"138","author":"Sanfelippo","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2019122611525797700_B46","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.5858\/2002-126-1326-AD","article-title":"Antithrombin deficiency: issues in laboratory diagnosis","volume":"126","author":"Kottke-Marchant","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2019122611525797700_B47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/humu.1380040105","article-title":"(ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations","volume":"4","author":"Olds","year":"1994","journal-title":"Hum Mutat"},{"issue":"10","key":"2019122611525797700_B48","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/jth.12364","article-title":"Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture","volume":"11","author":"Puurunen","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019122611525797700_B49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1160\/TH04-06-0384","article-title":"Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin","volume":"92","author":"Olson","year":"2004","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019122611525797700_B50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0049-3848(98)00079-6","article-title":"Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy","volume":"91","author":"Hansen","year":"1998","journal-title":"Thromb Res"},{"issue":"suppl 6","key":"2019122611525797700_B51","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"issue":"3","key":"2019122611525797700_B52","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0003-4975(00)01550-2","article-title":"A randomized trial of antithrombin concentrate for treatment of heparin resistance","volume":"70","author":"Williams","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"2019122611525797700_B53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/bjh.12975","article-title":"Measurement of non-coumarin anticoagulants and their effects on tests of haemostasis: guidance from the British Committee for Standards in Haematology","volume":"166","author":"Kitchen","year":"2014","journal-title":"Br J Haematol"},{"key":"2019122611525797700_B54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2019.01.007","article-title":"Monitoring of heparins in antithrombin-deficient patients","volume":"175","author":"Croles","year":"2019","journal-title":"Thromb Res"},{"issue":"suppl 1","key":"2019122611525797700_B55","first-page":"870","article-title":"Anticoagulation treatment with apixaban in inherited antithrombin deficiency [abstract]","volume":"101","author":"Bermejo","journal-title":"Haematologica"},{"issue":"22","key":"2019122611525797700_B56","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.2169\/internalmedicine.55.7314","article-title":"Edoxaban was effective for the treatment of deep vein thrombosis and pulmonary thromboembolism in a cancer patient with antithrombin III deficiency","volume":"55","author":"Kawano","year":"2016","journal-title":"Intern Med"},{"issue":"14","key":"2019122611525797700_B57","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2169\/internalmedicine.0483-17","article-title":"Efficacy of oral factor Xa inhibitor for venous thromboembolism in a patient with antithrombin deficiency","volume":"57","author":"Minami","year":"2018","journal-title":"Intern Med"},{"issue":"6","key":"2019122611525797700_B58","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.thromres.2013.04.016","article-title":"Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin","volume":"131","author":"Fukuda","year":"2013","journal-title":"Thromb Res"},{"issue":"8","key":"2019122611525797700_B59","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"2019122611525797700_B60","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/jth.13349","article-title":"Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis","volume":"14","author":"van Vlijmen","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2019122611525797700_B61","doi-asserted-by":"crossref","first-page":"j4452","DOI":"10.1136\/bmj.j4452","article-title":"Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis","volume":"359","author":"Croles","year":"2017","journal-title":"BMJ"},{"issue":"5","key":"2019122611525797700_B62","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10897-009-9239-7","article-title":"A pilot study to assess the feasibility of a multicenter cluster randomized trial for the management of asymptomatic persons with a thrombophilia","volume":"18","author":"Wells","year":"2009","journal-title":"J Genet Couns"},{"issue":"2","key":"2019122611525797700_B63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1538-7836.2011.04573.x","article-title":"Mortality and inherited thrombophilia: results from the European Prospective Cohort on Thrombophilia","volume":"10","author":"Pabinger","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019122611525797700_B64","first-page":"890","article-title":"Family history of venous thromboembolism as a risk factor and genetic research tool","volume":"114","author":"Z\u00f6ller","year":"2015","journal-title":"Thromb Haemost"},{"issue":"3B","key":"2019122611525797700_B65","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1016\/0002-9343(89)80533-9","article-title":"Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin","volume":"87","author":"Schwartz","year":"1989","journal-title":"Am J Med"},{"issue":"9","key":"2019122611525797700_B66","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/1060028016651276","article-title":"Issues in the diagnosis and management of hereditary antithrombin deficiency","volume":"50","author":"Bauer","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2019122611525797700_B67","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1076029609339748","article-title":"European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats","volume":"15","author":"Adiguzel","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"2019122611525797700_B68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-015-1309-0","article-title":"Guidance for the treatment and prevention of obstetric-associated venous thromboembolism","volume":"41","author":"Bates","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"22","key":"2019122611525797700_B69","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"2019122611525797700_B70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2141.2010.08094.x","article-title":"Managing anticoagulated patients during neuraxial anaesthesia","volume":"149","author":"Green","year":"2010","journal-title":"Br J Haematol"},{"issue":"9032","key":"2019122611525797700_B71","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"2019122611525797700_B72","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women","volume":"63","author":"Conard","year":"1990","journal-title":"Thromb Haemost"},{"issue":"2","key":"2019122611525797700_B73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000299460","article-title":"Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin","volume":"14","author":"Hellgren","year":"1982","journal-title":"Gynecol Obstet Invest"},{"key":"2019122611525797700_B74","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2017.05.017","article-title":"Management of hereditary antithrombin deficiency in pregnancy","volume":"157","author":"James","year":"2017","journal-title":"Thromb Res"},{"issue":"5","key":"2019122611525797700_B75","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019122611525797700_B76","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1160\/TH13-01-0077","article-title":"How I treat heterozygous hereditary antithrombin deficiency in pregnancy","volume":"110","author":"Bramham","year":"2013","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019122611525797700_B77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-5793(92)80854-A","article-title":"Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F","volume":"300","author":"Olds","year":"1992","journal-title":"FEBS Lett"},{"issue":"7","key":"2019122611525797700_B78","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019122611525797700_B79","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1055\/s-0037-1616525","article-title":"Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism","volume":"86","author":"Kuhle","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019122611525797700_B80","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1309\/AJCPY6G6ZITVKPVH","article-title":"The effect of dabigatran on select specialty coagulation assays","volume":"139","author":"Adcock","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2019122611525797700_B81","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1160\/TH17-08-0568","article-title":"Activated factor X-based versus thrombin-based antithrombin testing in thrombophilia workup in the DOAC era","volume":"118","author":"R\u00fchl","year":"2018","journal-title":"Thromb Haemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/26\/2346\/1549626\/bloodbld2019002927c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/26\/2346\/1549626\/bloodbld2019002927c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T04:07:49Z","timestamp":1664770069000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/26\/2346\/422690\/How-I-treat-patients-with-hereditary-antithrombin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":81,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2019,12,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019002927","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,26]]}}}